Denise Scots-Knight
CIK 1297000 · Chief Executive Officer · last filed 2026-05-26
Denise Scots-Knight is a Chief Executive Officer who has filed 41 SEC Form 4 insider transactions across 5 companies since 2007. The most recent filing, for ELAN, was dated May 26, 2026. Across all open-market trades the lifetime net is −$844.9K, making them a net seller over the disclosed history. Current disclosed insider exposure totals $2.6M across reported positions.
"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.
$2.59M
5
41
-$844.9K
Holdings By Company
| Symbol | Role | Shares | Price | Disclosed Exposure | Lifetime OM Net | Filings | Latest Filed |
|---|---|---|---|---|---|---|---|
| ELAN | Director | 105,588 | $22.12 | $2.34M | $0 | 6 | 2026-05-26 |
| MREO | Chief Executive Officer | 868,967 | $0.30 | $257.5K | -$844.9K | 7 | 2026-02-02 |
| Elanco Animal Health Inc (ELAT) Delisted | Director | 39,857 | $21.32 | $849.8K | $0 | 3 | 2022-12-02 |
| ALBIREO PHARMA, INC. (ALBO) Delisted | Director | 1,165,447 | $44.15 | $51.45M | $0 | 3 | 2017-06-20 |
| IDENIX PHARMACEUTICALS INC (IDIX) Delisted | Director | — | — | — | $0 | 8 | 2014-08-05 |
Recent Filings
41 filings| Filed | Symbol | Action | Net Shares | Net $ | Link |
|---|---|---|---|---|---|
| 2026-05-26 | ELAN | Grant (A) | +16,874 | $0 | EDGAR |
| 2026-02-02 | MREO | Grant (A) | — | $0 | EDGAR |
| 2025-12-02 | ELAN | Grant (A) | +10,314 | $0 | EDGAR |
| 2025-01-28 | MREO | Grant (A) | — | $0 | EDGAR |
| 2024-12-03 | ELAN | Grant (A) | +18,169 | $0 | EDGAR |
| 2024-09-16 | MREO | Sell (S) | −88,657 | -$381.4K | EDGAR |
| 2024-09-13 | MREO | Exer (M) | +188,060 | $0 | EDGAR |
| 2024-09-12 | — | Notice (144) | −88,657 | -$413.1K | EDGAR |
| 2024-06-27 | MREO | Sell (S) | −132,985 | -$463.5K | EDGAR |
| 2024-06-25 | MREO | Exer (M) | +282,090 | $0 | EDGAR |
Notice (144 / 144/A): Form 144 is a notice of intent to sell restricted/control stock under Rule 144, filed before the sale; 144/A is an amendment. Many notices are pre-scheduled under Rule 10b5-1 plans. A Form 4 with code S typically follows within a few days when the planned sale executes; missing follow-up Form 4s suggest the notice was cancelled or modified.